Everand Logo

Welcome to Everand!

  • STAT

    University of California squares off against major publisher, with big stakes for access to research

    by Rebecca Robbins Dec 19, 2018 1 minute
    The University of California campus in Berkeley.

    This story first appeared in “Go West,” STAT’s weekly newsletter about West Coast life sciences, health care, and biotech. Sign up here to receive it in your inbox. 

    SAN FRANCISCO — There’s a high-stakes fight in California

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
    Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
    Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

    Related